Researchers
-
Begoña Pina Marín
Ophthalmology
-
Carlos Luis Moser Würth
Ophthalmology
-
Carlos Martínez Belló
Ophthalmology
-
Diana Paola Mora Ramirez
Ophthalmology
-
Joan Josep Escobar Barranco
Ophthalmology
-
Josep Badal Lafulla
Ophthalmology
Phd -
Luis Amselem Gómez
Ophthalmology
-
Magela Garat Chifflet
Ophthalmology
-
Manel Fernández Bonet
Ophthalmology
-
Monica Lecumberri López
Ophthalmology
-
Rafael Alcubierre Bailac
Ophthalmology
-
Sabrina Bojados
Ophthalmology
-
Stephanie Carrillo
Ophthalmology
Contact the group
Form
Projects
-
- Year 2018
- Comprehensive Care Center Dos de Maig Hospital
Phase III, multicenter, randomized, double-masked, three-group, two-year study evaluating the efficacy and safety of brolucizumab versus aflibercept in adult patients with visual impairment due to diabetic macular edema,
-
DISTRICT ATTORNEY:
Novartis Farmacéutica, SA
-
TYPE E:
RD2015
-
- Year 2018
- Dos de Maig Hospital Integral Care Center
Phase III, multicenter, randomized, double-masked, three-group, two-year study evaluating the efficacy and safety of brolucizumab versus aflibercept in adult patients with visual impairment due to diabetic macular edema,
-
DISTRICT ATTORNEY:
Novartis Farmacéutica, SA
-
TYPE E:
RD2015
-
- Year 2018
- Comprehensive Care Center Dos de Maig Hospital
Phase III, multicenter, randomized, double-masked, active comparator-controlled study to evaluate the efficacy and safety of Faricimab in patients with neovascular age-related macular degeneration
-
DISTRICT ATTORNEY:
F. Hoffmann-La Roche Ltd
-
TYPE E:
RD2015
-
- Year 2018
- Comprehensive Care Center Dos de Maig Hospital
Multicenter, randomized, double-masked, controlled, phase III study with active comparator to evaluate the efficacy and safety of RO6867461 in patients with diabetic macular edema (DME),
-
DISTRICT ATTORNEY:
F. Hoffmann-La Roche Ltd
-
TYPE E:
RD2015
-
Ophthalmology
Researcher
- Year 2017
- Comprehensive Care Center Dos de Maig Hospital
Influence of clinical and genetic factors on long-term functional and anatomical evolution in a cohort of patients with wet AMD treated according to usual clinical practice,
-
DISTRICT ATTORNEY:
University of Navarra Clinic
-
TYPE E:
EPA
-
- Year 2017
- Comprehensive Care Center Dos de Maig Hospital
Influence of clinical and genetic factors on long-term functional and anatomical evolution in a cohort of patients with wet AMD treated according to usual clinical practice,
-
DISTRICT ATTORNEY:
Clinic University of Navarra
-
TYPE E:
EPA
-
- Year 2017
- Dos de Maig Hospital Integral Care Center
Influence of clinical and genetic factors on long-term functional and anatomical evolution in a cohort of patients with wet AMD treated according to usual clinical practice,
-
DISTRICT ATTORNEY:
University of Navarra Clinic
-
TYPE E:
EPA
-
Ophthalmology
Researcher
- Year 2016
- Comprehensive Care Center Dos de Maig Hospital
Multicenter, randomized, human intervention study of nutritional supplementation in patients with unilateral wet AMD,
-
DISTRICT ATTORNEY:
Thea Laboratories
-
TYPE E:
PI
-
Ophthalmology
Researcher
- Year 2016
- Comprehensive Care Center Dos de Maig Hospital
Interventional study in phase IV, multicenter and of a single group to evaluate a guideline to treat and extend with intravitreal aflibercept for the treatment of macular edema secondary to the occlusion of the central vein of the retina,
-
DISTRICT ATTORNEY:
Bayer AG
-
TYPE E:
RD2015
-
Ophthalmology
Researcher
- Year 2016
- Comprehensive Care Center Dos de Maig Hospital
Intravitreal ranibizumab in diabetic macular edema: clinical practice results,
-
DISTRICT ATTORNEY:
Jose Juan Escobar
-
TYPE E:
PI
Lines of action
- Treatment of retinal diseases with intravitreal medication
- Anti VEGF in diabetic macular edema
- Anti VEGF in central serous chorioretinopathy
- Treatment of Diabetic Retinopathy
- UTI (Intravitreal Therapy Unit)
- New techniques in cataract surgery
- Surgical alternatives to full thickness corneal transplantation
- Microkeratum assisted keratoplasty Anterior and posterior lamellar techniques
